← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Novoron Bioscience, Inc.
San Diego, CA
$4,772,878
Total funding
7
Grants
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,772,878 · 7
By mechanism
R41$2,146,445 · 4
R43$1,368,905 · 2
R44$1,257,528 · 1
Investigators at Novoron Bioscience, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Human iPSC neural spheroids to screen for compounds that block tau propagation$1,257,528
R44 · FY2025 · AG
NOVO-118 as a therapeutic to promote remyelination in in vivo models of MS$354,097
R41 · FY2020 · NS
RAP as a novel therapeutic to promote remyelination after MS demyelinating event$353,106
R43 · FY2015 · NS
NOVO-118 as a therapeutic to promote remyelination in in vivo models of MS$353,084
R41 · FY2019 · NS
A novel approach to restricting the spread of neurofibrillary tau$349,580
R41 · FY2021 · AG
A novel approach to restricting the spread of neurofibrillary tau$348,075
R41 · FY2022 · AG
Assessment of NOVO-118 as a regenerative therapeutic in acute spinal cord injury$347,542
R43 · FY2019 · NS
Assessment of NOVO-118 as a regenerative therapeutic in acute spinal cord injury$347,510
R43 · FY2018 · NS
RAP as a novel therapeutic to promote remyelination after MS demyelinating event$320,747
R43 · FY2016 · NS
RAP as a therapeutic for regeneration of the optic nerve after insult$225,000
R41 · FY2014 · EY
RAP as a therapeutic compound for neuronal regeneration after spinal cord injury$224,952
R41 · FY2014 · NS
A novel approach to restricting the spread of neurofibrillary tau$110,250
R41 · FY2022 · AG
RAP as a therapeutic compound for neuronal regeneration after spinal cord injury$80,122
R41 · FY2015 · NS
RAP as a therapeutic for regeneration of the optic nerve after insult$39,553
R41 · FY2015 · EY
A novel approach to restricting the spread of neurofibrillary tau$36,750
R41 · FY2022 · AG
RAP as a therapeutic compound for neuronal regeneration after spinal cord injury$24,982
R41 · FY2014 · NS